Premal Shah

Premal Shah serves as CEO at MyOme. MyOme operates in the research sector with approximately 52.0 employees. The company is headquartered in San Francisco, California. MyOme generates annual revenue of 2100000.0. To date, MyOme has raised 36000000.0 in total funding, with the most recent round being Series B.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,468 c suite-level executives.

Route 53 Amazon SES Gmail Google Apps Atlassian Cloud Google Font API Hubspot WordPress.org Mobile Friendly reCAPTCHA Eventbrite Google Tag Manager Android SharePoint Remote Python Flutter Circle AI

biotechnology research genomic testing whole genome sequencing bioinformatics personalized healthcare health risk assessment genetic insights proactive health tests diagnostic testing medication response polygenic risk score integrated risk assessment genetic counseling patient empowerment healthcare providers clinical utility data privacy hipaa compliance genetic diseases personalized medicine lifestyle assessments cancer risk heart disease assessment diabetes screening actionable reports single-gene testing rare disease genome patient data security easy test ordering health management health outcomes clinical support genomic data health diagnostics provider portal test performance compassionate care patient-centric approach genetic information data compliance genomic research health insights genetic analysis evidence-based medicine proactive diagnostics healthcare integration treatment optimization medical decision support anesthesia genetics patient safety information technology & services biotechnology

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Premal Shah in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at MyOme.

Premal Shah's Position in the MessageCEO Database

• •Premal Shah is 1 of 1 verified executive contact we track at MyOme.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •12,901 verified executive contacts in California are in the database.
• •15 verified contacts work at research companies in the 52.0 employee range (same size as MyOme).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Premal Shah directly?

Premal Shah's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at MyOme. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Premal Shah work for?

Premal Shah is CEO at MyOme, a company in the research sector with 52.0 employees. The company is based in San Francisco, California.

Can I pitch or sell to Premal Shah?

As CEO at MyOme, Premal Shah is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Premal Shah directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Premal Shah in?

Premal Shah works in the research industry as CEO at MyOme. MessageCEO provides verified contact information for executives across all major industries.

Is Premal Shah's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Premal Shah's profile is kept up-to-date with the latest available information.

Last updated: July 26, 2026